Alergologia Plus Sp. z o.o.
- Address
- lock Available on a paid plan
Immune System Diseases and Allergic Conditions
At Alergologia Plus Sp. z o.o. in Poznan, research in immune system diseases focuses on conditions such as atopic dermatitis, chronic spontaneous urticaria, and birch pollen-induced allergic rhinoconjunctivitis. These studies are designed to test new treatment options and compare them with existing therapies, with the goal of improving symptom control and long-term disease management.
- Testing new therapies for atopic dermatitis in children and adults
- Evaluating treatment options for chronic spontaneous urticaria
- Assessing relief strategies for allergic rhinoconjunctivitis caused by birch pollen
This area reflects a strong interest in better controlling allergic and inflammatory skin disorders while improving day-to-day comfort for patients.
Respiratory Tract Diseases
A major part of the research portfolio at Alergologia Plus Sp. z o.o. centers on respiratory tract diseases, especially asthma and chronic obstructive pulmonary disease. The trials are aimed at evaluating how well new and existing treatments reduce symptoms, improve lung function, and lower the risk of flare-ups in people with persistent breathing problems.
- Studying therapies for moderate-to-severe asthma and severe eosinophilic asthma
- Assessing treatment effectiveness in chronic obstructive pulmonary disease
- Exploring ways to reduce asthma exacerbations and improve lung function
The site contributes to research that aims to make breathing easier and reduce the burden of chronic airway inflammation.
Otorhinolaryngologic Diseases
Clinical studies in otorhinolaryngologic diseases at this research site focus on chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps. The main purpose is to evaluate therapies that may reduce nasal blockage, improve sinus symptoms, and lessen the impact of ongoing inflammation in the nose and sinuses.
- Research on chronic rhinosinusitis with nasal polyps
- Trials for chronic rhinosinusitis without nasal polyps
- Assessing treatments to improve nasal congestion and sinus-related symptoms
These studies support better care for patients living with long-lasting sinus disease and related breathing discomfort.
Skin and Connective Tissue Diseases
Research in skin and connective tissue diseases includes work on atopic dermatitis, a condition marked by chronic inflammation, itching, and skin irritation. The trials are focused on comparing therapies and improving disease control, especially for patients who need systemic treatment options.
- Evaluating new approaches for atopic dermatitis
- Comparing therapies to improve symptom relief and patient outcomes
- Supporting studies of inflammatory skin disease management
This research area highlights the site’s interest in advancing treatment choices for chronic skin inflammation and related quality-of-life concerns.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 61 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 61 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
lock +9 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Alergologia Plus Sp. z o.o.
lock Showing 1 of 42 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 52-week, randomised, double blind, multicentre, 2-arm parallel group trial assessing the efficacy and safety of CHF6001 (total daily dose 3200 μg) Dry Powder Inhaler (DPI) add-on to maintenance medium or high dose inhaled corticosteroid in combination with long-acting ß2-agonists in subjects with uncontrolled asthma | Chiesi Farmaceutici S.p.A. | Phase II | Not Recruiting | Nov 2023 | Dec 2025 |
IMP list
lock Showing 1 of 61 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Salbutamol Sulfate | 5 | Unknown | 2022-03-02 | 2026-05-19 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.